SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001628280-22-010131
Filing Date
2022-04-25
Accepted
2022-04-25 16:37:25
Documents
3
Period of Report
2022-04-25

Document Format Files

Seq Description Document Type Size
1 DEF 14A cort2022def14a.htm DEF 14A 817213
2 GRAPHIC corcepttherapeuticsincor001.jpg GRAPHIC 133233
3 GRAPHIC corcepttherapeuticsincor002.jpg GRAPHIC 149749
  Complete submission text file 0001628280-22-010131.txt   1208119
Mailing Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025
Business Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025 650.688.8803
CORCEPT THERAPEUTICS INC (Filer) CIK: 0001088856 (see all company filings)

IRS No.: 770487658 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-50679 | Film No.: 22850162
SIC: 2834 Pharmaceutical Preparations